Critical appraisal:Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al 2009
From Cancer Guidelines Wiki
Critical Appraisal
Article being appraised
Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009 Dec 20;27(36):6199-206 Available from: http://www.ncbi.nlm.nih.gov/pubmed/19917835.
Applicable clinical question
Key Facts
Study Design
cohort study
Study aims:
To revise the staging system for cutaneous melanoma on the basis of data from an expanded American Joint committee on Cancer (AJCC) melanoma staging database.
Number of Patients:
3307
30946 patients combined, 3307 stage III patients
Reported outcome(s):
Survival
Results of outcome(s):
Five-year survival was 59% for melanoma patients IIIB (P < .0001)
Includes an economic evaluation
no
Evidence ratings
Level of evidence
II
Risk of bias
Moderate risk of bias | Comments: Please replace this text and include any additional comments in regards to your risk of bias rating |
Result of appraisal
Completed by
- Article
- Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009 Dec 20;27(36):6199-206 Available from: http://www.ncbi.nlm.nih.gov/pubmed/19917835.
- Assigned to
- User:Lyndal.alchin
- Topic area
- Guidelines:Melanoma
- Clinical question
Section below only relevant for Cancer Council Project Officer